Galiximab, CAS [[357613-77-5]]

Produktübersicht

• Artikelname: Galiximab, CAS [[357613-77-5]]
• Artikelnummer: MCE-HY-P99293
• Hersteller Artikelnummer: HY-P99293
• Alternativnummer: MCE-HY-P99293-5MG,MCE-HY-P99293-1MG,MCE-HY-P99293-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: IDEC 114, Anti-Human CD80 Recombinant Antibody

Produktbeschreibung

Galiximab (IDEC-114) is a primatized monoclonal IgG1 antibody targeting CD80. Galiximab variable regions are primatized, and the constant regions are humanized. Galiximab induces antibody-dependent cellular cytotoxicity by blocking CD80-CD28 binding. Galiximab has antitumor activity and can induce apoptosis in tumor cells. Galiximab can be used in the research of relapsed Hodgkin lymphoma and solid tumors[1][2].

Produkteigenschaften

• Molekulargewicht: (145.24 kDa)
• Reinheit: 99.23
• CAS Nummer: [357613-77-5]
• Target-Kategorie: Apoptosis,CD28

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies